TRIBAL/TRIBA1AL and TRIB1 suppression in differentiated HepaRG cells. TRIBAL/TRIBA1AL and TRIB1 suppression in differentiated HepaRG cells

HepaRGs treated with antisense oligonucleotides targeting TRIBAL or TRIB1 (or Non-Target control) for 72 h Overall design: HepaRGs were concurrently treated with ASOs for 72 h. RNA was then isolated and reduction of the primary target (TRIBAL or TRIB1) was first confirmed by qRT-PCR. RNA was then subjected to Clariom_D assays.